The global bioprocess containers market is on a major growth path. Valued at around $3.12 billion in 2024, it’s expected to grow to $3.93 billion in 2025—and could reach nearly $31.91 billion by 2034. That’s a 26.07% annual growth rate, showing just how fast this industry is expanding.
Get All the Details in Our Solutions – Request a Brochure: https://www.towardshealthcare.com/download-brochure/5565
Bioprocess containers are flexible, single-use containers used in the pharmaceutical and biotech industries. They’re designed for safely storing and moving liquids like media, buffers, and waste during drug manufacturing and research. These containers help improve efficiency, reduce contamination risk, and cut costs since they don’t need cleaning after use.
North America led the market in 2024, making up 41% of global sales.
Asia Pacific is expected to grow the fastest over the next decade.
2D containers (flat-shaped) were the most used in 2024.
3D containers (cube-shaped) are growing the fastest, thanks to their flexibility and efficiency.
Upstream processes like cell growth and fermentation had the biggest share by application.
The production process segment is expected to grow quickly due to rising demand for biopharmaceuticals.
Pharmaceutical companies were the biggest users of these containers in 2024.
Biotech companies are expected to increase their usage the most in the coming years.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Rising demand for biologics like vaccines and cell therapies.
More use of single-use containers, which save time and reduce contamination.
New technologies and AI making manufacturing faster and more accurate.
Increased investment in healthcare R&D and facilities.
High initial costs of these containers, especially for small companies.
Strict quality standards can make production expensive.
Growing elderly population and chronic diseases are increasing the need for advanced drugs.
More biopharma manufacturing in regions like Asia and Latin America.
Sustainability focus is pushing the industry toward clean, disposable solutions.
To invest in our premium strategic solution and customized market report options, click here: https://www.towardshealthcare.com/price/5565
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More